Haemodialysis

N.2B. Quality of services and patient safety

1. Quality in practice - Diaverum paradigm

2. TBC

3. Policy on quality of services and patient safety in the Dialysis Units of the Greek National Health System

4. EN.I.N. Dialysis Unit Accreditation Program by HASIN

Breakthrough in Nephrology

N.5A. Changing the status quo in CKD

1. SGLT2 inhibitors: what's new? Dimitrios Vlahakos
2. The place of GLP-1 agonists in clinical practice Petros Kalogeropoulos

3. The place of MRAs in clinical practice Konstantinos Psounis

N.4A. IgA nephropathy

1. The role of B cells and BAFF/APRIL Dimitrios Bakoulis

2. New and emerging therapies in IgA nephropathy Panagiotis Kompotiatis

3. How should I manage the patient with IgA nephropathy Maria Stangou

N.6A. Hypertension

1. Management of hypertension in patients with CKD Georgios Hatzivasiliou

2. Resistant hypertension Vasileios Raptis

3. Use of diuretics in CKD: benefits and risks Eleni Intzevidou

4. Hypertension in dialysis Antonios Zagorianakos

N.3A. Cardiovascular morbidity in CKD

1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias

2. HIF inhibitors: their place in clinical practice Athena Gompou

3. Update in the management of hyperkalaemia Evdokia Efthymiou